StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Sanofi (SNY) Reports Q2 Loss of EUR0.07 on Revenues of EUR8.63B
July 29, 2019 5:58 AM
Sanofi (NASDAQ: SNY) reported Q2 EPS of (EUR0.07). Revenue for the quarter came in at EUR8.63 billion.Second-quarter 2019 sales growth(3) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
Earnings
Management Comments
Next Articles
UPDATE: Lexicon Pharma (LXRX) Reports Prelim. Update for Zynquista (Sotagliflozin) Type 2 Diabetes Phase 3 Program; Confirms Sanofi (SNY) to Terminate Collaboration
July 29, 2019 5:45 AM
Sanofi delivered solid growth in Q2 2019
July 29, 2019 1:30 AM
Sanofi (SNY) provided notice to Lexicon (LXRX) that it is terminating collaboration to develop, manufacture, and commercialize Zynquista
July 26, 2019 4:08 PM